Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial

Autor: Lorusso, D. ^*, Scambia, G., Pignata, S., Sorio, R., Amadio, G., Lepori, S., Mosconi, A., Pisano, C., Mangili, G., Maltese, G., Sabbatini, R., Artioli, G., Gamucci, T., Di Napoli, M., Capoluongo, E., Ludovini, V., Raspagliesi, F., Ferrandina, G.

Publikováno v: In Annals of Oncology March 2016 27(3):487-493

BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.

Autor: Mandalà M; University of Perugia, Perugia, Italy.; Unit of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Palmieri G; Immuno-Oncology & Targeted Cancer Biotherapies, University of Sassari, Sassari, Italy.; Unit of Cancer Genetics, IRGB-CNR, Sassari, Italy., Ludovini V; Unit of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Baglivo S; Unit of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Marasciulo F; Unit of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Castiglione F; Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy., Gili A; Unit of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Osella Abate S; Pathology Unit, Department of Medical Sciences, University of Torino, Torino, Italy., Rubatto M; Dermatology Unit, Department of Medical Sciences, University of Torino, Torino, Italy., Senetta R; Pathology Division, 'Città della Salute e della Scienza di Torino' University Hospital, Torino, Italy., Avallone G; Dermatology Unit, Department of Medical Sciences, University of Torino, Torino, Italy., Ribero S; Dermatology Unit, Department of Medical Sciences, University of Torino, Torino, Italy., Romano L; Unit of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Pimpinelli N; Unit of Dermatology, Department of Health Sciences, University of Florence Medical School, Florence, Italy., de Giorgi V; Unit of Dermatology, Department of Health Sciences, University of Florence Medical School, Florence, Italy., Roila F; University of Perugia, Perugia, Italy.; Unit of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Pisano M; Unit of Cancer Genetics, IRGB-CNR, Sassari, Italy., Casula M; Unit of Cancer Genetics, IRGB-CNR, Sassari, Italy., Manca A; Unit of Cancer Genetics, IRGB-CNR, Sassari, Italy., Sini MC; Unit of Cancer Genetics, IRGB-CNR, Sassari, Italy., Massi D; Section of Pathology, Department of Health Sciences, University of Florence, Florence, Italy., Quaglino P; Dermatology Unit, Department of Medical Sciences, University of Torino, Torino, Italy.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2023 Oct; Vol. 37 (10), pp. 1991-1998. Date of Electronic Publication: 2023 Jun 27.

High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients

Autor: Ludovini, V. ^*, Bellezza, G., Pistola, L., Bianconi, F., Di Carlo, L., Sidoni, A., Semeraro, A., Del Sordo, R., Tofanetti, F.R., Mameli, M.G., Daddi, G., Cavaliere, A., Tonato, M., Crinò, L.

Publikováno v: In Annals of Oncology May 2009 20(5):842-849

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion.

Autor: Aldea M; Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France; Paris-Saclay University, Kremlin-Bicêtre, France., Marinello A; Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France; Department of Medical Oncology, Humanitas Research Hospital, Milan, Italy., Duruisseaux M; Respiratory Department and Early Phase, Louis Pradel Hospital, Hospices Civils de Lyon; Cancer Research Center of Lyon (CRCL), INSERM 1052, CNRS 5286; Univ Lyon, Claude Bernard Lyon 1 University, Lyon, France., Zrafi W; Department of Biostatistics and Bioinformatics, Gustave Roussy, Villejuif, France., Conci N; Department of Medical Oncology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) University Hospital of Bologna, Bologna, Italy., Massa G; Department of Medical Oncology, National Cancer Institut, Milan, Italy., Metro G; Department of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Monnet I; Pneumology and Thoracic Oncology Department, Intercommunal Hospital of Creteil (CHI), Creteil, France., Gomez Iranzo P; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Tabbo F; Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Italy., Bria E; Department of Medical Oncology, Comprehensive Cancer Center, IRCCS Agostino Gemelli, Catholic University of the Sacred Heart, Rome, Italy., Guisier F; Department of Medical Oncology, Rouen University Hospital, Rouen, France., Vasseur D; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France., Lindsay CR; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Ponce-Aix S; Department of Medical Oncology, University Hospital October 12, Madrid, Spain., Cousin S; Department of Medical Oncology, Bergonié Institut, Bordeaux, France., Citarella F; Department of Medical Oncology, Campus Biomedico, Rome, Italy., Fallet V; Department of Pneumology and Thoracic Oncology, Tenon Hospital, Assistance Publique Hôpitaux de Paris and GRC 4, Theranoscan, Sorbonne Université, Paris, France., Minatta JN; Department of Medical Oncology, Hospital Italiano, Buenos Aires, Argentina., Eisert A; Department of Medical Oncology, University Hospital of Cologne, Cologne, Germany., de Saint Basile H; Department of Medical Oncology, European Hospital Georges Pompidou, Paris, France., Audigier-Valette C; Department of Medical Oncology, Hospital Sainte Musse, Toulon, France., Mezquita L; Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain; Laboratory of Translational Genomics and Targeted Therapies in Solid Tumors, Institut D'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Calles A; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Mountzios G; 4th Oncology Department and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece., Tagliamento M; Department of Internal Medicine and Medical Specialties, University of Genova, Genova, Italy., Remon Masip J; Department of Medical Oncology, Centro Integral Oncológico Clara Campal (HM-CIOCC), Hospital HM Delfos, HM Hospitales, Barcelona, Spain., Raimbourg J; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, St Herblain, France., Terrisse S; Department of Medical Oncology, Saint Louis Hospital, Paris, France., Russo A; Department of Medical Oncology, Papardo Hospital, Messina, Italy., Cortinovis D; Department of Medical Oncology, San Gerardo Hospital, Monza, Italy., Rochigneux P; Department of Medical Oncology, Paoli-Calmettes Institute, Marseille, France., Pinato DJ; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London, United Kingdom; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy., Cortellini A; Department of Medical Oncology, Campus Biomedico, Rome, Italy., Leonce C; Department of Molecular Pathology, Louis-Pradel Hospital, Lyon, France., Gazzah A; Department of Drug Development Department, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France., Ghigna MR; Department of Pathology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France., Ferrara R; Department of Medical Oncology, National Cancer Institut, Milan, Italy., Dall'Olio FG; Department of Biostatistics and Bioinformatics, Gustave Roussy, Villejuif, France., Passiglia F; Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, Italy., Ludovini V; Department of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Barlesi F; Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France; Paris-Saclay University, Kremlin-Bicêtre, France., Felip E; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Planchard D; Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France., Besse B; Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France; Paris-Saclay University, Kremlin-Bicêtre, France. Electronic address: benjamin.besse@gustaveroussy.fr.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 May; Vol. 18 (5), pp. 576-586. Date of Electronic Publication: 2023 Jan 13.

A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM : A case report.

Autor: Colombo M; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mondini P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Minenza E; Department of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Foglia C; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mosconi A; Department of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Molica C; Department of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Pistola L; Department of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Ludovini V; Department of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Mar 21; Vol. 13, pp. 1102184. Date of Electronic Publication: 2023 Mar 21 (Print Publication: 2023).